\n torage:\xa0\xa0
\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 4 ℃ for 6 months
Recovery:\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0
\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 Matrices listed belowere spiked with certain level of and the recovery rates were calculated by comparing the measured value to the expected amount of in samples.
| Matrix | Recovery range(%) | Average(%) |
| serum(n=5)\xa0\xa0\xa0\xa0\xa0 | 85-104 | 96 |
| EDTA plasma(n=5) | 88-103 | 96 |
| heparin plasma(n=5) | 88-104 | 98 |
| Matrix | Recovery range(%) | Average(%) |
| serum(n=5)\xa0\xa0\xa0\xa0\xa0 | 85-104 | 96 |
| EDTA plasma(n=5) | 88-103 | 96 |
| heparin plasma(n=5) | 88-104 | 98 |
| Matrix | Recovery range(%) | Average(%) |
Matrix | Matrix
Recovery range(%) | Recovery range(%)
Average(%) | Average(%)
| serum(n=5)\xa0\xa0\xa0\xa0\xa0 | 85-104 | 96 |
serum(n=5)\xa0\xa0\xa0\xa0\xa0 | serum(n=5)\xa0\xa0\xa0\xa0\xa0
85-104 | 85-104
96 | 96
| EDTA plasma(n=5) | 88-103 | 96 |
EDTA plasma(n=5) | EDTA plasma(n=5)
88-103 | 88-103
96 | 96
| heparin plasma(n=5) | 88-104 | 98 |
heparin plasma(n=5) | heparin plasma(n=5)
88-104 | 88-104
98 | 98 Linearity\xa0 :
\xa0\xa0\xa0\xa0\xa0\xa0\xa0 The linearity of the kit was assayed by testing samples spiked with appropriate concentration of and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4\xa0\xa0 | 1:8\xa0\xa0 | 1:16 |
| serum(n=5) | 90-105% | 88-105% | 90-98% | 86-104% \xa0 |
| EDTA plasma(n=5) | 82-93% | 82-93% | 82-93%\xa0\xa0\xa0\xa0 | 89-101% \xa0 |
| heparin plasma(n=5) | 80-97% | 81-98% | 81-99% | 93-100% \xa0 |
| Sample | 1:2 | 1:4\xa0\xa0 | 1:8\xa0\xa0 | 1:16 |
| serum(n=5) | 90-105% | 88-105% | 90-98% | 86-104% \xa0 |
| EDTA plasma(n=5) | 82-93% | 82-93% | 82-93%\xa0\xa0\xa0\xa0 | 89-101% \xa0 |
| heparin plasma(n=5) | 80-97% | 81-98% | 81-99% | 93-100% \xa0 |
| Sample | 1:2 | 1:4\xa0\xa0 | 1:8\xa0\xa0 | 1:16 |
Sample | Sample
1:2 | 1:2
1:4\xa0\xa0 | 1:4\xa0\xa0
1:8\xa0\xa0 | 1:8\xa0\xa0
1:16 | 1:16
| serum(n=5) | 90-105% | 88-105% | 90-98% | 86-104% \xa0 |
serum(n=5) | serum(n=5)
90-105% | 90-105%
88-105% | 88-105%
90-98% | 90-98%
86-104% \xa0 | 86-104%
\xa0
| EDTA plasma(n=5) | 82-93% | 82-93% | 82-93%\xa0\xa0\xa0\xa0 | 89-101% \xa0 |
EDTA plasma(n=5) | EDTA plasma(n=5)
82-93% | 82-93%
82-93% | 82-93%
82-93%\xa0\xa0\xa0\xa0 | 82-93%\xa0\xa0\xa0\xa0
89-101% \xa0 | 89-101%
\xa0
| heparin plasma(n=5) | 80-97% | 81-98% | 81-99% | 93-100% \xa0 |
heparin plasma(n=5) | heparin plasma(n=5)
80-97% | 80-97%
81-98% | 81-98%
81-99% | 81-99%
93-100% \xa0 | 93-100%
\xa0 \xa0
CV(%) :\xa0\xa0\xa0\xa0
\xa0\xa0\xa0\xa0\xa0 Intra-Assay: CV<8%
\xa0\xa0\xa0\xa0\xa0 Inter-Assay: CV<10%
Note\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 :
\xa0\xa0\xa0\xa0 For Research Use Only
\xa0
\xa0
\xa0
上海柯雷生物科技有限公司
Tel:13248085519Tel:13248085519
QQ: 1722105945
\xa0??